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Norbormide (NRB) is a unique compound that acts directly on rat vascular myocytes to
trigger a contractile process, through an as yet unknown mechanism, which results in
the selective contraction of rat peripheral arteries. To gain insight into the mechanisms
involved in NRB rat-selective activity, we investigated the subcellular distribution of
NRB-AF12, a nitrobenzoxadiazole (NBD)-derivative of NRB, in living NRB-sensitive
and NRB-insensitive cells. In both cell types, NRB-AF12 localized to the endoplasmic
reticulum (ER), Golgi apparatus, mitochondria, lysosomes, and endosomes; however,
in NRB-sensitive cells, the fluorescence also extended to the plasma membrane.
NRB-AF12 was rapidly internalized into the cells, could easily be washed out and then
reloaded back into the same cells, all with a high degree of reproducibility. Cells exposed
for 24 h to NRB-AF12 did not show apparent signs of toxicity, even at concentrations
of the dye (10µM) much higher than those required for fluorescence labeling (500
ηM). The distribution pattern of NRB-AF12 fluorescence was near identical to that of
ER-Tracker® (Er-Tr), a fluorescent derivative of glibenclamide, a known KATP channel
blocker. Displacement tests did not demonstrate, but at the same time did not rule out
the possibility of a common target for ER-Tr, NRB-AF12, NRB, and glibenclamide. On
the basis of these results we hypothesize a common target site for NRB-AF12 and ER-
Tr, and a similar target profile for NRB and glibenclamide, and propose NRB-AF12 as
an alternative fluorescence probe to ER-Tracker. Furthermore, NRB-based fluorescence
derivatives could be designed to selectively label single cellular structures.
Keywords: norbormide, ER tracker, fluorescent probes, sulphonylurea receptors, LX2 cells
INTRODUCTION
Norbormide (NRB, see Figure 1A for structure) is a unique vasoactive compound endowed with
species-specific vasoconstrictor activity that targets the peripheral blood vessels of the rat (Clarke,
1965; Roszkowski, 1965; Bova et al., 1996). It also provokes a vasorelaxant effect on arteries of
several non-rat species, as well as on rat large-caliber vessels (Roszkowski, 1965; Poos et al., 1966;
Cavalli et al., 2004). NRB is a mixture of up to eight stereoisomers, four endo-isomers and four
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FIGURE 1 | Chemical structures of (A) Norbormide and (B) its fluorescent derivative NRB-AF12. (C) Live cell imaging of LX2 hepatic stellate cells
fluorescently labeled with 500 ηM NRB-AF12 for 30 min. Magnification 40x; scale bar 20µm. (D) LX2 cells stained with NRB-AF12 were fixed and imaged by confocal
microscopy. Magnification 60x; scale bar 20µm.
exo-isomers; among them, only the endo-isomers demonstrate
vasocontractile and rat toxicant activities (Poos et al., 1966),
whereas both endo- and exo-isomers have vasodilatatory activity
in rat aorta and in non-rat arteries (Cavalli et al., 2004).
The contractile effect of NRB on rat peripheral blood vessels
is endothelium-independent, and is of myogenic nature as
confirmed by its action on single rat caudal artery myocytes
(Fusi et al., 2002; Cavalli et al., 2004). NRB binding sites and
the molecular mechanisms involved in its biological effects in
vascular tissue have yet to be fully characterized; it has been
proposed that NRB-induced vasoconstriction may result from
an interaction with a phospholipase C-coupled receptor (Bova
et al., 2001), whereas its relaxant effect may be caused by
an inhibitory action on plasma membrane voltage-dependent
L-type Ca2+ channels (Fusi et al., 2002). NRB has also been
shown to activate the mitochondrial permeability transition pore
(mPTP) in isolated rat mitochondria, but not in mitochondria
obtained from either guinea-pigs or mice. This suggests that the
effect on the mPTP, like NRB-vasoconstriction, is also species-
specific. However, since this effect could also be induced in
mitochondria isolated from different organs of the rat (Ricchelli
et al., 2005; Zulian et al., 2007, 2011), unlike vasoconstriction,
mPTP activation is not tissue-specific. It is therefore unclear
whether NRB-induced activation of the mPTP constitutes a role
in the vasoconstrictor effect of NRB.
Correspondingly, addressing the localization of NRB could
help characterize the molecular mechanisms underlying the
species- and tissue-selective actions of NRB; the original primary
objective of this study was therefore to develop a fluorescent
derivative of NRB (NRB-AF12, see Figure 1B for structure) in
order to compare its subcellular distribution in NRB-sensitive
and NRB-insensitive cells. However, since preliminary results
indicated a strong overlapping fluorescent distribution between
NRB-AF12 and that of ER-Tracker R© (ER-Tr), a commercially
available fluorescent probe widely used as a selective marker for
endoplasmic reticulum (ER), we extended our goals to include a
comparison of the staining profiles of the two dyes. The results
indicate that NRB-AF12 and ER-Tr show a near identical pattern
of fluorescence distribution in both NRB-sensitive and NRB-
insensitive cells, and that this fluorescence profile differs between
the two cell types. Furthermore, we found that both dyes label
not only ER (as would be expected with ER-Tr), but also Golgi
apparatus and mitochondria. In addition, unlike ER-Tr, NRB-
AF12 was also able to label lysosomes and endosomes.
MATERIALS AND METHODS
Chemistry
To a solution of endo-NRB (1.0 g, 2.0mmol) in DMF (6ml)
was added NaH (160mg, 4.0mmol, 60% w/w in oil), and
the resulting mixture stirred at room temperature for 15
min, then at 80◦C for a further 15min A solution of 4-
[(tert-butoxycarbonyl)amino]butyl methanesulfonate (Cao
et al., 2016) (0.59 g, 2.2mmol) in DMF (2ml) was added, and
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the resulting mixture stirred at 100◦C for 4 h. The reaction
mixture was then allowed to cool, diluted with water and
extracted with EtOAc. The separated organic phase was
washed with brine, dried over anhydrous Na2SO4, filtered
and the solvent removed in vacuo. Purification by column
chromatography (hexane/EtOAc, 1:1) afforded N-4′-[(tert-
butoxycarbonyl)amino] butyl-5-(α-hydroxy-α-2-pyridylbenzyl)-
7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide as
an endo-exclusive mixture of four stereoisomers (white solid;
1.09 g, 1.60mmol, 80%). 1HNMR (400MHz, CDCl3) δ 1.30-1.68
(13H, m, C(CH3)3 and NCH2CH2CH2CH2NH), 3.05-3.20
(2H, m, NCH2CH2CH2CH2NH), 3.24-3.70 (4.2H, m, H-2, H-3,
W/H-4 and NCH2CH2CH2CH2NH), 3.85–3.90 (0.4H, m, U/H-1
and V/H-1), 3.91-3.95 (0.4H, m, Y/H-4), 4.10–4.13 (0.1H, m,
U/H-4), 4.26–4.30 (0.3H, m, V/H-4), 4.42–4.48 (0.6H, m, W/H-1
and Y/H-1), 5.55–5.67 (1.7H, m, OH and V/H-6 and Y/H-6),
6.02–6.04 (0.1H, m, U/H-6), 6.05–6.07 (0.2H, m, W/H-6),
6.70–7.62 (16H, m, ArH), 8.66–8.39 (2H, m, αPyr). To a solution
of N-4′-[(tert-butoxycarbonyl)amino]butyl-5-(α-hydroxy-α-2-
pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-
dicarboximide (0.34 g, 0.5mmol) inDCM (10ml) was added TFA
(2ml), and the mixture stirred at room temperature for 3 h. The
solvent was then removed in vacuo to afford N-4′-aminobutyl-5-
(α-hydroxy-α-2-pyridylbenzyl)-7-(α-2-pyridylbenzylidene)-
5-norbornene-2,3-dicarboximide trifluoroacetate as an
endo-exclusive mixture of four stereoisomers [colorless gum
(quant.)], which was used without further purification. To a
solution of N-4′-aminobutyl-5-(α-hydroxy-α-2-pyridylbenzyl)-
7-(α-2-pyridylbenzylidene)-5-norbornene-2,3-dicarboximide
trifluoroacetate (100 mg, 0.14mmol) in DCM (4ml) was
added DIPEA (73 µl, 0.42mmol), and the mixture stirred
at room temperature for 30min. NBD-Cl (4-chloro-7-
nitrobenzofurazan) (28mg, 0.14mmol) was added and the
resulting mixture stirred at room temperature for a further
6 h. The mixture was then diluted with DCM, washed with
saturated aq. NaHCO3, then brine, and the separated organic
phase dried over anhydrous Na2SO4, filtered and the solvent
removed in vacuo. Purification by column chromatography
(DCM) afforded 5-(α-hydroxy-α-2-pyridylbenzyl)-N-4′-
[(7′′-nitro-2′′,1′′,3′′-benzoxadiazol-4”-yl)amino]butyl-7-(α-2-
pyridylbenzylidene)-5-norbornene-2,3-dicarboximide (NRB-
AF12) as an endo-exclusive mixture of four stereoisomers
(orange solid; 50mg, 0.067mmol, 48%). M.p. 108-112◦C;
1H NMR (400 MHz, CDCl3/MeOD 50:1 v/v) δ 1.61–
1.84 (4H, m, NCH2CH2CH2CH2N), 3.34–3.73 (6.2H, m,
NCH2CH2CH2CH2N, H-2, H-3 and W/H-4), 3.89–3.98 (0.7H,
m, V/H-1 and Y/H-4), 3.99–4.02 (0.1H, m, U/H-1), 4.18–4.24
(0.4H, m, V/H-4 and U/H-4), 4.28–4.38 (0.6H, m, Y/H-1 and
W/H-1), 5.56–5.62 (0.7H, m, V/H-6 and Y/H-6), 6.07–6.09
(0.1H, m, U/H-6), 6.12–6.14 (0.2H, m, W/H-6), 6.14–6.24 (1H,
m, H-5′′), 6.79–7.75 (16H, m, ArH), 8.37–8.65 (3H, m, αPyr and
H-6′′).
Fluorescence Spectra of NRB-AF12
Fluorescence spectra of NRB-AF 12 were obtained by dissolving
the dye in water (for details on the methodology see Figure S1 in
the Supplementary Material)
Cell Culture
LX2 (a human immortalized hepatic stellate cell line), HSC-T6 (a
rat immortalized hepatic stellate cell line), and HeLa (a human
cervical carcinoma cell line) cells were cultured at 37◦C in an
atmosphere of 5% CO2 in Dulbecco’s Modified Eagle Medium
(Euroclone - Milan, Italy) supplemented with 10% Fetal Bovine
Serum (Euroclone), 2 mM L-Glutamine and antibiotics. HepG2
cells (a human hepatocarcinoma cell line) were cultured at 37◦C
in an atmosphere of 5% CO2 in Eagle’s Minimum Essential
Medium (Euroclone) containing 10% Fetal Bovine Serum, 2mM
L-Glutamine and antibiotics.
VSMC Isolation
Smooth muscle cells were freshly isolated from the rat tail main
artery under the following conditions: a 5-mm long piece of
artery was incubated at 37◦C for 40–45min in 2ml of 0.1mM
Ca2+ external solution containing 20mM taurine, 1.35mg/ml
collagenase (type XI), 1mg/ml soybean trypsin inhibitor, and
1mg/ml BSA, which was lightly bubbled with a 95% O2–5% CO2
gas mixture to gently agitate the enzyme solution. Cells were
stored in 0.05mM Ca2+ external solution containing 20mM
taurine and 0.5mg/ml BSA at 4◦Cunder normal atmosphere, and
were used for experiments within 2 days following isolation (Fusi
et al., 2016).
Live-Cell Imaging
All cell lines tested were stained immediately before imaging.
Briefly, cells were trypsinized, counted and seeded in glass
bottom µ-Dishes (Ibidi - Munich, Germany) at 2 × 104
cells/dish, and incubated for 24 h at 37◦C in an atmosphere
of 5% CO2. Cells were rinsed with Dulbecco’s Modified Eagle
Medium without phenol red (Euroclone) and loaded with
500ηM NRB-AF12, 500ηM ER-Tr red or green (#E34250 and
#E34251; Thermo Fisher), and 500ηM pHrodo red (#P10361;
Thermo Fisher) at 10µg/ml. In another experiment, LX2 cells
were seeded in glass bottom µ-Dishes at 2 × 104 cells/dish
and incubated for 24 h at 37◦C in an atmosphere of 5%
CO2. Cells were transfected with either 500ηg of MitoDS-
red or KDEL-red vector using Lipofectamine LTX Reagent
(Invitrogen), according to the manufacturer specifications. At
24-h post-transfection, cells were stained with either 500ηM
NRB-AF12 or 500ηM ER-Tr green. Cells were mounted
in a Okolab microscope stage heated chamber warmed to
37◦C. All images were collected with a Yokogawa CSU-X1
spinning disk confocal on a Nikon Ti-E inverted microscope
equipped with a Plan Apo 60x NA 1.4 objective. Probes
were excited with a 488 and 561 nm Lasers. To separate
the individual emissions a dichroic filter 405/488/561/635-25
(Semrock, Rochester, NY) followed by a 440-40/521-21/607-
34/700-45 filter (Semrock, Rochester, NY) were used and
subsequently filtered further using band-pass filters (Semrock
BP-525/30-25 and BP-607/36-25 for the green and red channels,
respectively). Images were acquired with an Andor Technology
iXon3 DU-897-BV EMCCD camera. For time-lapse experiments,
images were collected every 10 s, using an exposure time of
500ms.
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Immunocytochemistry
To evaluate cell retention of the probe post-
fixation/permeabilization, LX2 cells (2 × 104) were plated
on a 12mm glass coverslip placed in a well of a 24 well-plate
and incubated for 24 h at 37◦C in an atmosphere of 5% CO2.
The cells were then treated with 500ηM NRB-AF12 for 30 min,
fixed with 4% paraformaldehyde for 15 min at room temperature
and immediately mounted on microscope slides, or fixed with
4% paraformaldehyde, permeabilized with either 0.1% Triton
X-100 (10min at room temperature) or ice cold methanol (5min
at−20◦C), and subsequently mounted.
In order to evaluate NRB-AF12 co-localization with
endoplasmic reticulum, Golgi apparatus and with the
sulfonylurea receptor (SUR) subunits of the ATP-sensitive
potassium channels, cells were fixed with 4% paraformaldehyde
for 15 min at room temperature, and permeabilized with ice
cold methanol for 5min at −20◦C. ER was highlighted with
antibodies directed against the ER resident protein calreticulin
(1:200; Abcam #ab2907); Golgi apparatus was highlighted with
antibodies directed against the Golgi apparatus structural protein
GM130 (1:500; BD Biomedsciences #610822); SUR2 subunits of
KATP channel were highlighted using either anti-SUR2A (1:750;
Abcam #ab174629) or anti-SUR2B (1:750; Abcam #ab174631)
antibodies. All primary antibodies were incubated for 90 min at
room temperature. Following a PBS wash, cells were incubated
with CyTM3 goat anti-rabbit IgG fluorescent secondary antibody
(1:500; Jackson ImmunoResearch #111-165-003) or with CyTM3
goat anti mouse IgG fluorescent secondary antibody (1:500;
KPL #072-01-18-06) for 60 min at room temperature in the
presence of either 500ηM NRB-AF12 or 500ηM ER-Tr green.
Finally, coverslips were mounted on microscope slides using
Mowiol 40–88 (Sigma Aldrich). Confocal images were acquired
with a Laser Scanning Confocal Microscope (LSCM) D-Eclipse
C1 SHV Nikon system equipped with a Nikon Eclipse E600
microscope and 3 laser diode modules (488/543/637 nm), using
a CFI Plan Apochromat 60x NA 1.4 objective and analyzed using
NIS Elements software (Nikon) and the open-source platform
for biological-image analysis Fiji software.
Drosophila melanogaster
Drosophila strain W[1118], stock number 5905 was obtained
from Bloomington stock center (Indiana University, USA)
FIGURE 2 | (A) Live cell imaging of LX2 cells transfected with ER-reporter RFP-KDEL plasmid and subsequently stained with NRB-AF12. (B) Immunostaining of LX2
cells for the endoplasmic reticulum marker calreticulin; cells were counter-labeled with NRB-AF12. (C) Confocal live cell imaging of LX2 cells fluorescently labeled with
500ηM NRB-AF12 and 500ηM ER-Tr red. Insets show magnification of the pictures. Magnification 60x; scale bar 10µm. (D) Quantification of NRB-AF12
co-localization with RFP-KDEL, Calreticulin and ER-Tr is shown as Pearson’s coefficient. (n ≥ 10).
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and used to perform live imaging experiments. Fly larvae
having reached the third instar stage whilst feeding on
standard food were dissected in hemolymph-like HL3
saline (70mM NaCl, 5mM KCl, 1.5mM CaCl2, 20mM
MgCl2, 10mM NaHCO3, 5mM trehalose, 115mM sucrose,
5mM sodium HEPES, pH 7.2). For live tissue imaging
ER-Tr red and NRB-AF12 were added to the medium of
dissected larvae and images acquired using a Nikon eclipse C1
confocal microscope and a Nikon Fluor 60x NA 1.00 water
objective.
Biocompatibility
1 × 105 LX2 cells, 1 × 105 HepG2 cells and 5 × 104
HSC-T6 cells were plated in 12 well-plates in complete
culture medium and incubated for 24 h at 37◦C. Cells
were then treated with increasing doses (0.1, 1 and 10µM)
of NRB, NRB-AF12, glibenclamide and ER-Tr for 24 h.
Cell viability was assessed by the Trypan Blue exclusion
method. Briefly, cells were trypsinized, resuspended in complete
medium, diluted 1:2 with a 0.4% Trypan Blue solution
and finally counted using a hemacytometer under a light-
microscope.
Hazards Related to the Use of NRB and Its
Derivatives for Research Purposes
In HSNO (Hazardous Substances and New Organisms) terms,
a substance is considered hazardous if it triggers any one
of the threshold levels for any of the hazardous properties
listed in the USA Environmental Protection Agency (EPA)
guidelines, one of which is toxicity. NRB is extremely toxic
to rats and as such is classified as an “extremely hazardous
chemical” in the US and elsewhere. However, one of the
key features of NRB is that its toxic activity is uniquely
limited to rats, having little or no activity in any other species
tested (including humans). In fact NRB’s lethal activity is
even further restricted as it seems only to be toxic to species
within the Rattus genus, with other rat genera being little
or not affected. As a consequence, the NRB and the NRB
derivatives reported in this research paper poses little or no
hazard to the researchers, and as such no special conditions or
safety precautions are required to work with these substances
other than those required to conform to standard laboratory
practices.
Statistical Analysis
All values are expressed as means ± standard error (SE) of n
observations/group. Analysis of co-localization was performed
using Pearson’s correlation coefficient. Comparisons of more
than two groups were made with a one-way ANOVA using
post-hoc Tukey’s test. Comparison of two groups was obtained
by the Student’s t-test for unpaired data when appropriate.
Differences were considered statistically significant at values of
P < 0.05.
FIGURE 3 | (A) Live cell imaging of LX2 cells transfected with ER-reporter RFP-KDEL plasmid and subsequently stained with ER-Tr. (B) Immunostaining of LX2 cells
for the endoplasmic reticulum marker calreticulin; cells were counter-labeled with NRB-AF12. Magnification 60x; scale bar 10µm. (C) Quantification of ER-Tr
co-localization with RFP-KDEL and Calreticulin is shown as Pearson’s coefficient (n ≥ 10).
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RESULTS
The fluorescence spectra of NRB-AF12 are shown in Figure S1 in
Supplementary Material.
The distribution of NRB-AF12 was initially evaluated in NRB-
insensitive cells.
Figure 1C shows phase contrast microscopy images and
conventional epifluorescence microscopy images of living LX2
cells incubated with 500ηM NRB-AF12. The images clearly
show a meshwork distribution of the fluorescence with a sharp
demarcation of the nuclei and an accumulation in perinuclear
areas; moreover, NRB-AF12 did not stain either the nuclei or
the plasma membrane. NRB-AF12 internalization into the cell
was fast, commencing after only a few seconds and reaching
completion within a few minutes, following its addition to the
incubation medium. A similar fluorescence pattern was also
observed in fixed LX2 cells (Figure 1D), however, the NRB-AF12
signal was not retained post-permeabilization (data not shown).
The sub-cellular distribution of NRB-AF12 was investigated
in more detail in LX2 cells using confocal microscopy in
combination with fluorescent probes and/or antibodies targeted
to specific subcellular structures. To evaluate the distribution
of NRB-AF12 in the ER, LX2 cells were transfected with the
ER-reporter red fluorescent protein (RFP)-KDEL plasmid and
subsequently loaded with the dye. The results, reported in
Figures 2A,D, show that the NRB-AF12 signal significantly
overlapped with that of (RFP)-KDEL (Pearson’s Coefficient:
0.21 ± 0.10; n ≥ 10), but a larger staining distribution of
NRB-AF12 was observed which indicated other targets in
addition to ER. Similar results were observed in LX2 fixed cells
labeled with NRB-AF12 and immunostained for the ER resident
protein Calreticulin (Pearson’s Coefficient: 0.3 ± 0.06; n ≥ 10)
(Figures 2B–D). We also compared the staining pattern of NRB-
AF12 with that of ER-Tr, a commercial fluorescent probe widely
used to label ER. Surprisingly, co-labeling of LX2 cells with NRB-
AF12 and ER-Tr resulted in a strong overlap between fluorescent
dyes (Figure 2C), confirmed by the high rate of co-localization
index (Pearson’s coefficient: 0.75± 0.02; n≥ 15). This remarkable
similarity between the two dyes was further supported by the
observation that ER-Tr, as well as NRB-AF12, were not selective
FIGURE 4 | Representative live cells microphotographs showing co-localization between NRB-AF12 (left column) and ER-Tr red (mid column) in (A)
HepG2, (B) HSC-T6, (C) HeLa, and (D) primary rat vascular smooth muscle cells (VSMC) from caudal artery. For each panel, merged fluorescence is shown
in right column. Magnification 60x; scale bar, 10µm. (E) Quantification of NRB-AF12 and ER-Tr co-localization is shown as Pearson’s coefficient (n ≥ 15).
Frontiers in Pharmacology | www.frontiersin.org 6 September 2016 | Volume 7 | Article 315
D’Amore et al. Fluorescent NRB-AF12 Labels Intracellular Structures
FIGURE 5 | LX2 fixed cells immunostained for the Golgi apparatus structural protein GM130; cells were counter-labeled with (A) NRB-AF12 or (B)
ER-Tr green. Magnification 60x; scale bar 10µm. (C) Co-localization measure is shown as Pearson’s coefficient (n ≥ 10).
FIGURE 6 | Live cell imaging of liver myofibroblasts transfected with the mitochondrial marker Mito-Ds red and then stained using (A) NRB-AF12 or
(B) ER-Tr green. Magnification 60x; scale bar 10µm. (C) Co-localization of NRB-AF12 and ER-Tr within mitochondria is reported as Pearson’s coefficient (n ≥ 10).
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for the ER, as demonstrated by co-staining LX2 cells with ER-Tr
plus either RFP-KDEL (Figure 3A) or Calreticulin (Figure 3B)
(Pearson’s coefficient: 0.23± 0.1 and 0.29± 0.03, respectively for
RFP-KDEL and Calreticulin; n ≥ 10; Figure 3C).
The NRB-AF12 and ER-Tr subcellular distribution patterns
and co-localization rates were confirmed using other NRB-
insensitive cells (i.e., HepG2, HSC-T6, and HeLa cells;
Figures 4A–C), and using NRB-sensitive cells such as freshly
isolated rat caudal artery myocytes (Figure 4D). Interestingly,
in this latter cell type, both fluorescent compounds stained not
only intracellular structures, but also the plasma membrane.
Co-localization rates of NRB-AF12 and ER-Tr in HepG2,
HSC-T6, HeLa and primary rat vascular smooth muscle cells
is reported in Figure 4E as Pearson’s coefficient. These results
indicates that NRB-AF12 labels intracellular structures with a
pattern of distribution that is apparently very similar to that of
ER-Tr, and is not confined to ER.
We then investigated, using LX2 cells, which non-ER
subcellular organelles were labeled by NRB-AF12, and compared
the results with those obtained with ER-Tr, focusing our
attention on the Golgi apparatus, mitochondria, lysosomes, and
endosomes.
The Golgi apparatus was investigated by co-staining fixed
cells with either NRB-AF12 or ER-Tr, and antibodies directed
against the Golgi structural protein GM130 (α-GM130). Data
obtained, shown in Figure 5A, indicates a co-localization of
NRB-AF12 and α-GM130 (Pearson’s coefficient: 0.53 ± 0.02; n
≥ 10; Figure 5C). Similar results were obtained when α-GM130
was used in combination with ER-Tr (Pearson’s coefficient: 0.58
± 0.02; n ≥ 10; Figures 5B,C).
Mitochondrial NRB-AF12 and ER-Tr localization
was investigated in living LX2 cells transfected with the
mitochondrial marker MitoDS-red plasmid, and then loaded
with either NRB-AF12 or ER-Tr. As depicted in Figure 6, both
dyes labeled mitochondria to similar levels (Pearson’s Coefficient:
0.56 ± 0.05 and 0.54 ± 0.03, respectively for NRB-AF12 and
ER-Tr; n ≥ 10).
Next, we investigated whether NRB-AF12 and ER-Tr could
label endosomes and lysosomes. For this purpose, we performed
live cell imaging experiments in LX2 cells using a commercial
fluorescent probe which has been previously demonstrated to
highlight vesicles involved in endocytosis. As shown in Figure 7,
we could not find any staining of endocytic vesicles when cells
were loaded with ER-Tr (Pearson’s coefficient: −0.33 ± 0.05
and −0.43 ± 0.04, respectively for endosomes and lysosomes;
n ≥ 10). In contrast, NRB-AF12 showed an appreciable co-
localization rate with both endosomal and lysosomal vesicles
(Pearson’s coefficient 0.25± 0.13 and 0.15± 0.15, respectively; n
≥ 10). Interestingly, the data revealed a high index of dispersion
of the co-localization coefficients (CI 95%: −0.05 – 0.55 and
FIGURE 7 | Confocal live cell microphotographs of LX2 cells stained with the fluorescent dye for endosomal (empty arrowhead) and lysosomal (full
arrowhead) compartments pHrodo red and (A) NRB-AF12 or (B) ER-Tr green. Magnification 60x; scale bar 10µm. (C,D) Co-localization of NRB-AF12 and
ER-Tr Green with endosome and lysosome vesicles is shown as Pearson’s coefficient (*p < 0.05; n ≥ 10).
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FIGURE 8 | (A,B) Confocal pictures of LX2 fixed cells immunostained for the KATP channels subunit SUR2A and counter-labeled with (A) NRB-AF12 or (B) ER-Tr
green. (C,D) Immunostaining of LX2 cells for SUR2B subunit of KATP channels; cells were counter-labeled with (C) NRB-AF12 or (D) ER-Tr green. Insets show
magnification of the pictures. Magnification 60x; scale bar 10 µm. (E,F) Pearson’s coefficient showing co-localization rate of (E) NRB-AF12 or (F) ER-Tr green with
either SURs isoforms (n ≥ 15).
−0.19 – 0.5, for endosomes and lysosomes respectively; n ≥ 10),
indicating that not all endosomes/lysosomes vesicles were stained
by the dye.
Since NRB-AF12 and ER-Tr showed the same cellular labeling
pattern, we hypothesized a common target for these compounds.
ER-Tr probes are conjugates of glibenclamide bearing different
fluorophores, BODIPY FL (ER-Tr green) and BODIPY TR (ER-
Tr red). Glibenclamide is an antidiabetic drug belonging to
the class of sulfonylureas that binds the sulfonylurea receptor
(SUR) subunits of ATP-sensitive potassium channels (Proks
et al., 2002). Accordingly, we therefore explored the likelihood
of whether NRB could also target these SURs by analyzing the
co-localization between NRB-AF12 and the 2 major subunits
SUR2A and SUR2B. We focused our attention on these SUR
isoforms because of their intracellular distribution (Bao et al.,
2011) and the role of the plasmalemmal SUR2B in the regulation
of vascular contraction (Morrissey et al., 2005; Teramoto, 2006;
Jackson, 2008; Tinker et al., 2014). Our results indicate that in
LX2 cells NRB-AF12 co-localized with both SUR2A and SUR2B,
with a greater correlation for the latter (Pearson’s coefficient: 0.28
± 0.02 and 0.36 ± 0.01, respectively for SUR2A and SUR2B; n
≥ 10) (Figures 8A,C,E); comparable results were also obtained
with ER-Tr (Pearson’s coefficient: 0.22 ± 0.04 and 0.32 ± 0.02,
respectively for SUR2A and SUR2B; n ≥ 10) (Figure 8B,D,F). It
is worth noting that the cellular distribution of NRB-AF12 and
ER-Tr fluorescence was larger than that observed with SUR2,
suggesting non-SUR2 additional targets for both dyes.
The overlapping fluorescence distributions of AF-12
and ER-Tr prompted us to investigate whether NRB and
glibenclamide could compete with their respective fluorescent
derivatives in LX2 cells. To this end, LX2 cells were pre-
treated with high concentrations (100µM) of either NRB
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FIGURE 9 | Confocal live imaging of Drosophila (A) muscles and (B) tracheal system labeled with NRB-AF12 (green) and ER-Tr red (red). Both
fluorescent dyes, added to the dissected larva in HL3 physiological solution, show an overlapping pattern of distribution as highlight by the yellow signal of the merged
images (*: muscle; white arrowhead: trachea; N: nucleus). Magnification 60x; scale bar 10µm.
or glibenclamide, and then loaded with either NRB-AF12
or ER-Tr. Interestingly, pre-treatment with the non-
labeled compounds failed to prevent fluorescent labeling
following addition of the fluorescent derivatives (data not
shown).
To summarize the results concerning the cellular distribution
of AF-12, we show in Figure 10 a single living LX2 cell, in which
are detailed the subcellular organelles labeled by the dye.
We also explored the fluorescence features of NRB-AF12 in
intact tissues of dissected larvae of Drosophila melanogaster.
Third instar larvae were labeled with NRB-AF12 and ER-Tr
dissolved in the hemolymph-like HL3 saline, added to the
medium following dissection and imaged with an immersion
objective. As shown in Figure 9, a bright fluorescence was
observed when larvae were treated with the fluorescent
probes: In vivo live imaging of D. melanogaster muscle
fibers (Figure 9A) and tracheal system (Figure 9B) revealed a
sarcoplasmic reticulum distribution of the dyes, with NRB-
AF12 and ER-Tr fluorescence significantly overlapping, as
was observed in cell culture (Johnson et al., 2015). Finally,
we investigated some physical properties of NRB-AF-12 such
as penetration, internalization rate, retention time, washout
time-course in living cells, as well as the induction of
cytotoxicity, in order to establish the usefulness and reliability
of the dye. Video 1 in Supplementary Material, shows that
in living LX2 cells AF-12 is internalized in minutes and is
retained in the cells for at least 3 h following its removal
from the culture medium. Furthermore, re-exposure of the
cells to dye, gave the same results, in terms of fluorescence
distribution, compared to the first exposure. NRB-AF12 was
apparently not toxic in both human and rat cell lines, even at
concentrations much higher than those (500 nM) utilized for
labeling (Figures 11B–D).
DISCUSSION
This study was undertaken to verify if a fluorescent derivative
of NRB could furnish information about the cellular target/s
involved in the selective rat-specific and tissue-selective action of
unlabeled NRB. To this end, we attached the NBD fluorophore
to the NRB molecule. The NBD group is known to bleach very
rapidly in respect to other commercially available fluorophores,
nevertheless we decided to use NBD because of its relatively
small size, in the attempt to minimize the risk of inducing
a distortion of the chemical-physical properties of NRB. We
compared the fluorescence distribution of NBD-NRB (NRB-
AF12) observed in NRB-sensitive cells (freshly isolated rat caudal
artery myocytes) with that observed in NRB-insensitive cells
(several cultured cell lines). Preliminary experiments conducted
in our lab indicated that NRB-AF12 has the same species-
and tissue-specific contractile properties of unlabeled NRB
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FIGURE 10 | Confocal live imaging of a LX2 cell stained with NRB-AF12
showing subcellular distribution of the fluorescent probe. Magnification
100x; scale bar 5µm.
(manuscript in preparation), and therefore is a reliable tool for
the purpose of this work.
There are two key observations:
1) In both NRB-sensitive and NRB-insensitive cells NRB-AF12
distributes intracellularly; however, only in the sensitive cells
is fluorescence detected in the plasma membrane.
2) In all the cells investigated, NRB-AF12 fluorescence showed a
pattern of distribution similar to that of ER-Tr.
Given that the cellular labeling patterns of NRB-AF12 and
ER-Tr are near identical, it could be proposed that the two
dyes share a common cellular target/s. ER-Tr is a BODIPY
derivative of glibenclamide, a widely used antidiabetic drug
belonging to the sulfonylurea family. Glibenclamide is a non-
selective inhibitor of ATP-sensitive potassium channels (Proks
et al., 2002), a multimeric protein complex consisting of four
pore-lining inward rectifier α subunits (Kir6.1/2) and four
regulatory sulfonylurea-binding β subunits (SUR1/2A/2B) that
belong to the ATP-binding cassette family (Yokoshiki et al.,
1998; Zerangue et al., 1999; Shi et al., 2005; Ng et al., 2010).
Co-assembly of different Kir and SUR subunits generates ion
channel combinations with different channel properties, and
with different cell compartment or tissue distribution (Yokoshiki
et al., 1998), such as the SUR1/Kir6.2 pancreatic type, the
SUR2A/Kir6.2 cardiac type and the SUR2B/Kir6.1 vascular
smooth muscle type. The ER-Tr and NRB-AF12 fluorescence
characteristics may therefore reflect the cellular distribution of
KATP channels. Inhibition of plasma membrane ATP-sensitive
potassium channels leads to an increased intracellular K+
concentration, plasma membrane depolarization, opening of
voltage-dependent calcium channels, and increased intracellular
Ca2+ concentration (Ko et al., 2008) that, in vascular smooth
muscle, triggers the contractile process. It has been reported that
vascular smooth muscle plasma membrane selectively expresses
SUR2B subunits of KATP channels (Morrissey et al., 2005;
Teramoto, 2006; Tinker et al., 2014). These data, together
with the finding (this study) that NRB-AF12 localizes to the
plasma membrane only in NRB-sensitive cells, might explain the
species- and tissue-selective activity of NRB, by hypothesizing an
inhibitory effect of the drug on rat-specific SUR2B-containing
KATP channels expressed on the plasma membrane of the rat
peripheral artery myocytes. In contrast to this hypothesis is the
fact that neither unlabeled NRB nor glibenclamide are able to
displace NRB-AF12 or ER-Tr from their binding site, which
presents the prospect of a different/additional site of action
from/to KATP channels. It also raises the question as to whether
the fluorescently labeled compounds have the same binding
characteristics of the corresponding unlabeled compounds.
However, the lack of displacement is in itself not sufficient
to rule out the possibility that NRB-AF12 does bind to KATP
channels, with there being at least two plausible explanations:
(1) NRB-AF12 and NRB could bind to different sites within the
SUR2Bmoiety, thus allowing the attachment of both compounds;
(2) the fluorophore group of NRB-AF12 may have multiple
binding sites preventing its displacement by unlabeled NRB. The
existence of more than one binding site, at least for NRB-AF12,
is supported by the fact that this dye, in contrast to ER-Tr, was
able to label both endosomes and lysosomes. As with SUR2-
containing channels, NRB-AF12 appears to be similarly targeted
to the endosomal/lysosomal pathway, supporting the idea that
this compound can be recycled by endocytosis as has been shown
for the KATP channel subunits (Bao et al., 2011).
Live cell imaging represents an important technique in the
study of biological processes; the use of fluorescent proteins or
dyes provides an important tool for the in vivo visualization,
in space, and time, of virtually any cellular mechanism or
structure, avoiding artifacts or sample alteration that could
occur with fixation methods. In this study we show that NRB-
AF12 is endowed with features that make this dye an eligible
prototype of new fluorescent probes, alternatives to ER-Tr, for
live cell imaging (Figure 10). Furthermore, in NRB-sensitive
single rat vascular myocytes, this dye, due to its constriction
effect (manuscript in preparation), could also be employed to
study the morphologic changes that occur in labeled intracellular
organelles, as well as in the plasma membrane, during the
contractile process. Whatever the binding site/s for NRB-AF12,
this dye shows a cellular distribution near identical to that of
ER-Tr in real-time fluorescent imaging using different cultured
cell lines and freshly isolated rat caudal artery myocytes. NRB-
AF12 labeling was also observed in fixed and permeabilized
cells, allowing its use in immunocytochemistry co-localization
experiments. In all cells tested, NRB-AF12 stained not only ER,
but also other subcellular compartments such as Golgi apparatus,
mitochondria, and organelles involved in the endocytic pathway
(i.e., endosomes and lysosomes). NRB-AF12 internalization rate
was extremely fast, since cell incubation with the fluorescent
compound resulted in a well-defined meshwork staining of the
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FIGURE 11 | (A) LX2 cells were incubated for 30 min with NRB-AF12 or ER-Tr green; after replacing the staining solution with probe-free medium, evaluation of
NRB-AF12 and ER-Tr extent of fluorescent signal and photostability was performed. (B) LX2, (C) HSC-T6, and (D) HepG2 cells were treated for 24 h with increasing
doses (0.1, 1 and 10µM) of NRB, NRB-AF12, glibenclamide or ER-Tr. Compounds toxicity was evaluated by trypan blue exclusion test of cell viability. NT, not treated
cells.
cellular structures within a few minutes, and could be observed
up to 3 h following its removal from the culture medium
(Figure 11A). Another useful feature is that NRB-AF12 exhibited
no apparent cytotoxicity, a serious disadvantage that often occurs
using fluorescent probes for live cell imaging. Cell viability
experiments demonstrated the dye to be biocompatible, having
no harmful effects in the different cell lines (both human and
rat) after 24-h incubation, even at concentrations (10µM) much
higher than those (500ηM) needed to visualize cellular organelles
(Figures 11B–D). Furthermore, the lack of cytotoxicity of NRB-
AF12 allows the same sample to be repeatedly stained with the
dye (for example at different time points within an experiment),
without morphological alteration of cell structures or cell death;
concurrently, the ability of NRB to effectively label its cellular
target is preserved on re-exposure to the dye (Figure 11A).
Finally, imaging experiments performed in dissected
larvae of D. melanogaster demonstrated NRB-AF12
adaptability in complex biological systems. The live
imaging of fly tissues showed that NRB-AF12 maintain
the same subcellular distribution of ER-Tr also in vivo,
supporting the theory of a common target. Moreover, we
observed a significant signal in the Drosophila tracheal
system where Drosophila Sur (Dsur) is highly expressed
(Nasonkin et al., 1999). Dsur, encodes a glibenclamide-
sensitive potassium channel and has been identified as the
functional orthologue of the mammalian SUR2 (Kim and
Rulifson, 2004). On the basis of these favorable properties,
we propose NRB-AF12 as an alternative fluorescent dye to
ER-Tr, and a new improved tool for labeling intracellular
organelles.
In conclusion, this study presents evidence to demonstrate
that NRB-AF12, a fluorescent derivative of the selective rat
toxicant NRB, has a highly similar fluorescence distribution to
ER-Tr, a fluorescent derivative of glibenclamide, a known KATP
channel inhibitor. On the basis of these results we hypothesize
common cellular binding sites for NRB and glibenclamide
that may potentially lead to common biological properties.
Furthermore, we propose NRB-AF12 as a prototype for the
development of new fluorescent probes selective for intracellular
structures/organelles. Studies are in progress in our lab to
investigate these aspects.
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